The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns

scientific article

The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/IJE/DYI062
P698PubMed publication ID15831565
P5875ResearchGate publication ID7904730

P2093author name stringKoopman JS
Jacobsen KH
P2860cites workA survey on hepatitis A in Portuguese children and adolescents.Q43338911
Hepatitis A seroprevalence rate in SyriaQ43340067
The prevalence of antibody to hepatitis A virus in SingaporeQ43514300
Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, TurkeyQ43674686
Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.Q44019728
Prevalence of hepatitis A antibodies in southeastern Spain: a population-based studyQ44316383
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisationQ44388264
Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey.Q44560831
Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in ItalyQ44753531
Childhood epidemiology of hepatitis A virus in Riyadh, Saudi ArabiaQ45406500
Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccinationQ45723040
Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990.Q45755942
Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern SpainQ45772142
Prevalence of antibody to hepatitis A virus among children in Trabzon, TurkeyQ45775303
Racial differences in the seroprevalence of hepatitis A virus infection in Natal/KwaZulu, South AfricaQ45784932
Hepatitis A virus infection in householdsQ45792939
Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, JapanQ45799013
A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, JapanQ45831222
Hepatitis B virus infection in children in Sardinia, ItalyQ45843198
Age-specific prevalence of hepatitis A virus antibody in Ethiopian childrenQ45849113
Changing patterns of hepatitis A virus infection in children in Palermo, ItalyQ45849225
Declining prevalence of antibodies to hepatitis: A virus infection in icelandQ45863698
Early asymptomatic hepatitis A in Senegalese childrenQ46929802
A model of long-term decline in the transmissibility of an infectious disease: implications for the incidence of hepatitis A.Q50194724
Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.Q50906394
Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population.Q53984237
A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.Q55240047
The intensity of transmission of hepatitis A and heterogeneities in socio-environmental risk factors in Rio de Janeiro, BrazilQ57166871
Current seroepidemiology of hepatitis A in Hong KongQ58236472
Declining hepatitis A seroprevalence: a global review and analysis.Q36001458
Age-specific antibody prevalence to hepatitis A in England: implications for disease controlQ36503452
Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern SpainQ36504318
Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groupsQ36523327
Seroprevalence of viral hepatitis A in the Czech RepublicQ38466425
Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi ArabiaQ39190704
Hepatitis A shifting epidemiology in the Middle East and AfricaQ39192407
Studies on antibody to hepatitis A virus in children and adults in LondonQ39205709
Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markersQ39339695
The changing epidemiologic pattern of hepatitis A infection in urban GreeceQ39339724
Age-specific prevalence of hepatitis A virus antibody in ThailandQ39341827
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east ItalyQ39349463
Prevalence of antibody to hepatitis A in Iceland in relation to age, sex, and number of notified cases of hepatitisQ39359693
Prevalence of antibody against hepatitis A in Sweden in relation to age and type of communityQ39367205
Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, BrazilQ39374665
Decline in anti-HAV prevalence in the Milan area between 1958 and 1992.Q39386401
Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain).Q39417743
Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil.Q39517399
Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factorsQ39529783
Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98).Q39573621
The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factorsQ39584931
Preliminary Serologic Studies of Antibody to Hepatitis A Virus in Populations in the United StatesQ40027647
The Changed Epidemiology of Hepatitis A Infection in ScandinaviaQ40162730
Decrease in incidence of hepatitis a infections in GermanyQ40198163
Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveysQ40717078
The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based surveyQ40748632
The changing epidemiology of hepatitis A in children and the consideration of active immunization in KoreaQ40772354
Population-based survey of hepatitis A virus infection in the Republic of San MarinoQ40879842
Epidemiology of hepatitis A in Valencia, Spain: public health implications.Q41007986
IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy StudyQ41468038
Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West GreenlandQ42984845
Hepatitis A, B and C seroprevalence in PakistanQ43036975
Epidemiology of hepatitis A in Mediterranean countriesQ43309783
Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factorsQ43333584
P433issue3
P921main subjectsocioeconomicsQ1643441
seroprevalenceQ3511357
Hepatitis A virusQ4112120
hepatitis AQ157661
P304page(s)600-609
P577publication date2005-04-14
P1433published inInternational Journal of EpidemiologyQ6051393
P1476titleThe effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns
P478volume34

Reverse relations

cites work (P2860)
Q81572029A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China
Q38252498A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region
Q33541273A review of data needed to parameterize a dynamic model of measles in developing countries
Q40044938A statistical model to estimate the impact of a hepatitis A vaccination programme
Q37421432Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012.
Q36075046Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review
Q35465620Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia
Q34757384Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas
Q35533510Challenges to mapping the health risk of hepatitis A virus infection
Q35993848Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults
Q39628691Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka
Q33265523Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.
Q37394565Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh
Q57385730Comparative hepatitis A seroepidemiology in 10 European countries
Q43807408Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
Q35093540Decreasing risk of hepatitis A infection in León, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies
Q37002452Detection and Molecular Characterization of Hepatitis A Virus from Tunisian Wastewater Treatment Plants with Different Secondary Treatments.
Q58130211Do medical college students living in hostel in India need hepatitis A vaccine?
Q26784450Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol
Q41125396Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men.
Q33933442Evidence of hepatitis A virus person-to-person transmission in household outbreaks.
Q40347139Fecal‐Orally Transmitted Diseases Among Travelers Are Decreasing Due to Better Hygienic Standards at Travel Destination
Q54263022Globalization and the Changing Epidemiology of Hepatitis A Virus.
Q33553107Hepatitis A among refugees, asylum seekers and migrants living in hosting facilities, Greece, April to December 2016.
Q63245087Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis
Q82218124Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine
Q34989500Hepatitis A surveillance and vaccine use in China from 1990 through 2007
Q36970157Hepatitis A vaccination in developing countries: Is Syria next?
Q34013577Hepatitis A virus in West Africa: Is an epidemiological transition beginning?
Q38231524Hepatitis A virus in the Middle East and North Africa region: a new challenge
Q34132177Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.
Q93046069Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015
Q37337759Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran.
Q33603873High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo
Q35230459High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran
Q43353874High prevalence of anti-hepatitis A virus immunoglobulin G antibody among healthcare facility attendees in Osogbo, Nigeria
Q85064985Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years
Q33619565Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay
Q36175752Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review
Q42224674Incidence and molecular characterization of hepatitis A viruses in Korean surface water between 2007 and 2010.
Q26866356Live attenuated hepatitis A vaccines developed in China
Q44756993Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.
Q44789022Mathematical modeling and the epidemiological research process
Q38933049Modeling the hepatitis A epidemiological transition in Thailand
Q35138754Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus
Q34308655Pattern of hepatitis a incidence according to area characteristics using national health insurance data
Q37356170Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
Q40056662Prevalence of G6PD deficiency in Children with Hepatitis A.
Q42287066Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany
Q40124975Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study
Q52668904Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.
Q38617154Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia.
Q36917182Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study
Q90435614Risk factors for viral hepatitis A infection in Gampaha District, Sri Lanka: an unmatched case control study
Q37083095Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan
Q39834918Seroprevalence of hepatitis A virus among Iranian soldiers
Q36412278Seroprevalence of hepatitis a and associated factors among 1-15 year old children in Eastern Turkey
Q34725927Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults
Q43344549Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.
Q37703292Spatial analysis of the home addresses of hospital patients with hepatitis B infection or hepatoma in Shenzhen, China from 2010 to 2012
Q33833205Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran
Q45336096The Syrian refugees crisis brings challenges to the health authorities in Europe: hepatitis A virus is a case in point
Q33321690The United States and Canada as a coupled epidemiological system: an example from hepatitis A
Q34132167The costs of hepatitis A infections in South Korea.
Q47160922The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
Q93038262The global epidemiology of viral-induced acute liver failure: a systematic review protocol
Q45384697The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
Q40051750The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited
Q64923093The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.
Q44038112Use of a catalytic model to estimate hepatitis A incidence in a low-endemicity country: implications for modeling immunization policies

Search more.